Request for Covid-19 Impact Assessment of this Report
The United States Hepatitis A and B Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Hepatitis A and B Vaccine market, reaching US$ million by the year 2028. As for the Europe Hepatitis A and B Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Hepatitis A and B Vaccine players cover GSK, Merck, Sanofi, and Sinovac, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis A and B Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Hepatitis A Vaccination
Hepatitis B Vaccination
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Government Institution
Private Sector
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
Serum Institute
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hepatitis A and B Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hepatitis A and B Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hepatitis A and B Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Hepatitis A and B Vaccine Segment by Type
2.2.1 Hepatitis A Vaccination
2.2.2 Hepatitis B Vaccination
2.3 Hepatitis A and B Vaccine Sales by Type
2.3.1 Global Hepatitis A and B Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Hepatitis A and B Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hepatitis A and B Vaccine Sale Price by Type (2017-2022)
2.4 Hepatitis A and B Vaccine Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Hepatitis A and B Vaccine Sales by Application
2.5.1 Global Hepatitis A and B Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Hepatitis A and B Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Hepatitis A and B Vaccine Sale Price by Application (2017-2022)
3 Global Hepatitis A and B Vaccine by Company
3.1 Global Hepatitis A and B Vaccine Breakdown Data by Company
3.1.1 Global Hepatitis A and B Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Hepatitis A and B Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Hepatitis A and B Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Hepatitis A and B Vaccine Revenue by Company (2020-2022)
3.2.2 Global Hepatitis A and B Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Hepatitis A and B Vaccine Sale Price by Company
3.4 Key Manufacturers Hepatitis A and B Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis A and B Vaccine Product Location Distribution
3.4.2 Players Hepatitis A and B Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hepatitis A and B Vaccine by Geographic Region
4.1 World Historic Hepatitis A and B Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Hepatitis A and B Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hepatitis A and B Vaccine Annual Revenue by Geographic Region
4.2 World Historic Hepatitis A and B Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Hepatitis A and B Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hepatitis A and B Vaccine Annual Revenue by Country/Region
4.3 Americas Hepatitis A and B Vaccine Sales Growth
4.4 APAC Hepatitis A and B Vaccine Sales Growth
4.5 Europe Hepatitis A and B Vaccine Sales Growth
4.6 Middle East & Africa Hepatitis A and B Vaccine Sales Growth
5 Americas
5.1 Americas Hepatitis A and B Vaccine Sales by Country
5.1.1 Americas Hepatitis A and B Vaccine Sales by Country (2017-2022)
5.1.2 Americas Hepatitis A and B Vaccine Revenue by Country (2017-2022)
5.2 Americas Hepatitis A and B Vaccine Sales by Type
5.3 Americas Hepatitis A and B Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis A and B Vaccine Sales by Region
6.1.1 APAC Hepatitis A and B Vaccine Sales by Region (2017-2022)
6.1.2 APAC Hepatitis A and B Vaccine Revenue by Region (2017-2022)
6.2 APAC Hepatitis A and B Vaccine Sales by Type
6.3 APAC Hepatitis A and B Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hepatitis A and B Vaccine by Country
7.1.1 Europe Hepatitis A and B Vaccine Sales by Country (2017-2022)
7.1.2 Europe Hepatitis A and B Vaccine Revenue by Country (2017-2022)
7.2 Europe Hepatitis A and B Vaccine Sales by Type
7.3 Europe Hepatitis A and B Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hepatitis A and B Vaccine by Country
8.1.1 Middle East & Africa Hepatitis A and B Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hepatitis A and B Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Hepatitis A and B Vaccine Sales by Type
8.3 Middle East & Africa Hepatitis A and B Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis A and B Vaccine
10.3 Manufacturing Process Analysis of Hepatitis A and B Vaccine
10.4 Industry Chain Structure of Hepatitis A and B Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis A and B Vaccine Distributors
11.3 Hepatitis A and B Vaccine Customer
12 World Forecast Review for Hepatitis A and B Vaccine by Geographic Region
12.1 Global Hepatitis A and B Vaccine Market Size Forecast by Region
12.1.1 Global Hepatitis A and B Vaccine Forecast by Region (2023-2028)
12.1.2 Global Hepatitis A and B Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hepatitis A and B Vaccine Forecast by Type
12.7 Global Hepatitis A and B Vaccine Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Hepatitis A and B Vaccine Product Offered
13.1.3 GSK Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Hepatitis A and B Vaccine Product Offered
13.2.3 Merck Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Hepatitis A and B Vaccine Product Offered
13.3.3 Sanofi Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sinovac
13.4.1 Sinovac Company Information
13.4.2 Sinovac Hepatitis A and B Vaccine Product Offered
13.4.3 Sinovac Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sinovac Main Business Overview
13.4.5 Sinovac Latest Developments
13.5 Zhejiang Pukang
13.5.1 Zhejiang Pukang Company Information
13.5.2 Zhejiang Pukang Hepatitis A and B Vaccine Product Offered
13.5.3 Zhejiang Pukang Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zhejiang Pukang Main Business Overview
13.5.5 Zhejiang Pukang Latest Developments
13.6 Changchun Institute of Biological
13.6.1 Changchun Institute of Biological Company Information
13.6.2 Changchun Institute of Biological Hepatitis A and B Vaccine Product Offered
13.6.3 Changchun Institute of Biological Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Changchun Institute of Biological Main Business Overview
13.6.5 Changchun Institute of Biological Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Hepatitis A and B Vaccine Product Offered
13.7.3 KM Biologics Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 IMBCAMS
13.8.1 IMBCAMS Company Information
13.8.2 IMBCAMS Hepatitis A and B Vaccine Product Offered
13.8.3 IMBCAMS Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 IMBCAMS Main Business Overview
13.8.5 IMBCAMS Latest Developments
13.9 Convac
13.9.1 Convac Company Information
13.9.2 Convac Hepatitis A and B Vaccine Product Offered
13.9.3 Convac Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Convac Main Business Overview
13.9.5 Convac Latest Developments
13.10 NCPC
13.10.1 NCPC Company Information
13.10.2 NCPC Hepatitis A and B Vaccine Product Offered
13.10.3 NCPC Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 NCPC Main Business Overview
13.10.5 NCPC Latest Developments
13.11 Bio Kangtai
13.11.1 Bio Kangtai Company Information
13.11.2 Bio Kangtai Hepatitis A and B Vaccine Product Offered
13.11.3 Bio Kangtai Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Bio Kangtai Main Business Overview
13.11.5 Bio Kangtai Latest Developments
13.12 Dynavax
13.12.1 Dynavax Company Information
13.12.2 Dynavax Hepatitis A and B Vaccine Product Offered
13.12.3 Dynavax Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Dynavax Main Business Overview
13.12.5 Dynavax Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Hepatitis A and B Vaccine Product Offered
13.13.3 Hissen Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
13.14 LG Life Sciences
13.14.1 LG Life Sciences Company Information
13.14.2 LG Life Sciences Hepatitis A and B Vaccine Product Offered
13.14.3 LG Life Sciences Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 LG Life Sciences Main Business Overview
13.14.5 LG Life Sciences Latest Developments
13.15 Serum Institute
13.15.1 Serum Institute Company Information
13.15.2 Serum Institute Hepatitis A and B Vaccine Product Offered
13.15.3 Serum Institute Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Serum Institute Main Business Overview
13.15.5 Serum Institute Latest Developments
14 Research Findings and Conclusion
Table 1. Hepatitis A and B Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Hepatitis A and B Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Hepatitis A Vaccination
Table 4. Major Players of Hepatitis B Vaccination
Table 5. Global Hepatitis A and B Vaccine Sales by Type (2017-2022) & (Units)
Table 6. Global Hepatitis A and B Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Hepatitis A and B Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Hepatitis A and B Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Hepatitis A and B Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Hepatitis A and B Vaccine Sales by Application (2017-2022) & (Units)
Table 11. Global Hepatitis A and B Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Hepatitis A and B Vaccine Revenue by Application (2017-2022)
Table 13. Global Hepatitis A and B Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Hepatitis A and B Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Hepatitis A and B Vaccine Sales by Company (2020-2022) & (Units)
Table 16. Global Hepatitis A and B Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Hepatitis A and B Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Hepatitis A and B Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Hepatitis A and B Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Hepatitis A and B Vaccine Producing Area Distribution and Sales Area
Table 21. Players Hepatitis A and B Vaccine Products Offered
Table 22. Hepatitis A and B Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hepatitis A and B Vaccine Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Hepatitis A and B Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Hepatitis A and B Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Hepatitis A and B Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Hepatitis A and B Vaccine Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Hepatitis A and B Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Hepatitis A and B Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Hepatitis A and B Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Hepatitis A and B Vaccine Sales by Country (2017-2022) & (Units)
Table 34. Americas Hepatitis A and B Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Hepatitis A and B Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Hepatitis A and B Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Hepatitis A and B Vaccine Sales by Type (2017-2022) & (Units)
Table 38. Americas Hepatitis A and B Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Hepatitis A and B Vaccine Sales by Application (2017-2022) & (Units)
Table 40. Americas Hepatitis A and B Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Hepatitis A and B Vaccine Sales by Region (2017-2022) & (Units)
Table 42. APAC Hepatitis A and B Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Hepatitis A and B Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Hepatitis A and B Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Hepatitis A and B Vaccine Sales by Type (2017-2022) & (Units)
Table 46. APAC Hepatitis A and B Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Hepatitis A and B Vaccine Sales by Application (2017-2022) & (Units)
Table 48. APAC Hepatitis A and B Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Hepatitis A and B Vaccine Sales by Country (2017-2022) & (Units)
Table 50. Europe Hepatitis A and B Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Hepatitis A and B Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Hepatitis A and B Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Hepatitis A and B Vaccine Sales by Type (2017-2022) & (Units)
Table 54. Europe Hepatitis A and B Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Hepatitis A and B Vaccine Sales by Application (2017-2022) & (Units)
Table 56. Europe Hepatitis A and B Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Hepatitis A and B Vaccine Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Hepatitis A and B Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Hepatitis A and B Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Hepatitis A and B Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Hepatitis A and B Vaccine Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Hepatitis A and B Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Hepatitis A and B Vaccine Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Hepatitis A and B Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Hepatitis A and B Vaccine
Table 66. Key Market Challenges & Risks of Hepatitis A and B Vaccine
Table 67. Key Industry Trends of Hepatitis A and B Vaccine
Table 68. Hepatitis A and B Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Hepatitis A and B Vaccine Distributors List
Table 71. Hepatitis A and B Vaccine Customer List
Table 72. Global Hepatitis A and B Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Hepatitis A and B Vaccine Sales Market Forecast by Region
Table 74. Global Hepatitis A and B Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Hepatitis A and B Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Hepatitis A and B Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Hepatitis A and B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Hepatitis A and B Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Hepatitis A and B Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Hepatitis A and B Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Hepatitis A and B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Hepatitis A and B Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Hepatitis A and B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Hepatitis A and B Vaccine Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Hepatitis A and B Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Hepatitis A and B Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Hepatitis A and B Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Hepatitis A and B Vaccine Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Hepatitis A and B Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Hepatitis A and B Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Hepatitis A and B Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. GSK Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Hepatitis A and B Vaccine Product Offered
Table 94. GSK Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Merck Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Hepatitis A and B Vaccine Product Offered
Table 99. Merck Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Sanofi Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Hepatitis A and B Vaccine Product Offered
Table 104. Sanofi Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Sinovac Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Sinovac Hepatitis A and B Vaccine Product Offered
Table 109. Sinovac Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Sinovac Main Business
Table 111. Sinovac Latest Developments
Table 112. Zhejiang Pukang Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhejiang Pukang Hepatitis A and B Vaccine Product Offered
Table 114. Zhejiang Pukang Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Zhejiang Pukang Main Business
Table 116. Zhejiang Pukang Latest Developments
Table 117. Changchun Institute of Biological Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Changchun Institute of Biological Hepatitis A and B Vaccine Product Offered
Table 119. Changchun Institute of Biological Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Changchun Institute of Biological Main Business
Table 121. Changchun Institute of Biological Latest Developments
Table 122. KM Biologics Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. KM Biologics Hepatitis A and B Vaccine Product Offered
Table 124. KM Biologics Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. KM Biologics Main Business
Table 126. KM Biologics Latest Developments
Table 127. IMBCAMS Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. IMBCAMS Hepatitis A and B Vaccine Product Offered
Table 129. IMBCAMS Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. IMBCAMS Main Business
Table 131. IMBCAMS Latest Developments
Table 132. Convac Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Convac Hepatitis A and B Vaccine Product Offered
Table 134. Convac Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Convac Main Business
Table 136. Convac Latest Developments
Table 137. NCPC Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. NCPC Hepatitis A and B Vaccine Product Offered
Table 139. NCPC Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. NCPC Main Business
Table 141. NCPC Latest Developments
Table 142. Bio Kangtai Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Bio Kangtai Hepatitis A and B Vaccine Product Offered
Table 144. Bio Kangtai Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Bio Kangtai Main Business
Table 146. Bio Kangtai Latest Developments
Table 147. Dynavax Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Dynavax Hepatitis A and B Vaccine Product Offered
Table 149. Dynavax Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Dynavax Main Business
Table 151. Dynavax Latest Developments
Table 152. Hissen Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. Hissen Hepatitis A and B Vaccine Product Offered
Table 154. Hissen Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Hissen Main Business
Table 156. Hissen Latest Developments
Table 157. LG Life Sciences Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 158. LG Life Sciences Hepatitis A and B Vaccine Product Offered
Table 159. LG Life Sciences Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. LG Life Sciences Main Business
Table 161. LG Life Sciences Latest Developments
Table 162. Serum Institute Basic Information, Hepatitis A and B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 163. Serum Institute Hepatitis A and B Vaccine Product Offered
Table 164. Serum Institute Hepatitis A and B Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Serum Institute Main Business
Table 166. Serum Institute Latest Developments
List of Figures
Figure 1. Picture of Hepatitis A and B Vaccine
Figure 2. Hepatitis A and B Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hepatitis A and B Vaccine Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Hepatitis A and B Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Hepatitis A and B Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Hepatitis A Vaccination
Figure 10. Product Picture of Hepatitis B Vaccination
Figure 11. Global Hepatitis A and B Vaccine Sales Market Share by Type in 2021
Figure 12. Global Hepatitis A and B Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Hepatitis A and B Vaccine Consumed in Government Institution
Figure 14. Global Hepatitis A and B Vaccine Market: Government Institution (2017-2022) & (Units)
Figure 15. Hepatitis A and B Vaccine Consumed in Private Sector
Figure 16. Global Hepatitis A and B Vaccine Market: Private Sector (2017-2022) & (Units)
Figure 17. Hepatitis A and B Vaccine Consumed in Other
Figure 18. Global Hepatitis A and B Vaccine Market: Other (2017-2022) & (Units)
Figure 19. Global Hepatitis A and B Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global Hepatitis A and B Vaccine Revenue Market Share by Application in 2021
Figure 21. Hepatitis A and B Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Hepatitis A and B Vaccine Revenue Market Share by Company in 2021
Figure 23. Global Hepatitis A and B Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Hepatitis A and B Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Hepatitis A and B Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global Hepatitis A and B Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Hepatitis A and B Vaccine Sales 2017-2022 (Units)
Figure 28. Americas Hepatitis A and B Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Hepatitis A and B Vaccine Sales 2017-2022 (Units)
Figure 30. APAC Hepatitis A and B Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Hepatitis A and B Vaccine Sales 2017-2022 (Units)
Figure 32. Europe Hepatitis A and B Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Hepatitis A and B Vaccine Sales 2017-2022 (Units)
Figure 34. Middle East & Africa Hepatitis A and B Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Hepatitis A and B Vaccine Sales Market Share by Country in 2021
Figure 36. Americas Hepatitis A and B Vaccine Revenue Market Share by Country in 2021
Figure 37. United States Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Hepatitis A and B Vaccine Sales Market Share by Region in 2021
Figure 42. APAC Hepatitis A and B Vaccine Revenue Market Share by Regions in 2021
Figure 43. China Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Hepatitis A and B Vaccine Sales Market Share by Country in 2021
Figure 50. Europe Hepatitis A and B Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Hepatitis A and B Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Hepatitis A and B Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Hepatitis A and B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Hepatitis A and B Vaccine in 2021
Figure 64. Manufacturing Process Analysis of Hepatitis A and B Vaccine
Figure 65. Industry Chain Structure of Hepatitis A and B Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...